We had shown that, in breast cancer cells, apigenin interacts with the RNA-binding proteins MSI2 and hnRNPA227, which regulate alternative splicing of DR5 and c-FLIP, respectively, and also with Hsp70. This evidence concerns the gene MSI2 and breast carcinoma.